ClearanceBrief
510(k) K223405 ยท CDZ Radioimmunoassay, Testosterones And Dihydrotestosterone

Access Testosterone

ApplicantBeckman Coulter, Inc., Chaska MN, US
DecisionSubstantially Equivalent, Jan 13, 2023
ReceivedNov 9, 2022
TypeTraditional
FDA recordOpen on fda.gov

Recalls that name K223405

DateFirm and productCodeLinked 510(k)
Jun 2, 2025Beckman Coulter, Inc.
Access Testosterone assay, Catalog Number 33560
Open, Classified
CDZNone listed

Links come from the 510(k) numbers listed on each FDA recall record. We don't infer predicate chains.